Navigation Links
MU researchers find synthetic RNA lessens severity of fatal disease
Date:11/21/2011

COLUMBIA, Mo. A team of University of Missouri researchers have found that targeting a synthetic molecule to a specific gene could help the severity of the disease Spinal Muscular Atrophy (SMA) the leading genetic cause of infantile death in the world.

"When we introduced synthetic RNA into mice that carry the genes responsible for SMA, the disease's severity was significantly lowered," said Chris Lorson, researcher at the Bond Life Sciences Center and professor in the Department of Veterinary Pathobiology and the Department of Molecular Microbiology and Immunology. "The mice that receive synthetic RNA gain more weight, live longer, and had improvements in motor skills. These results are very exciting."

SMA is a rare genetic disease that is inherited by one in 6,000 children, who often die young because there is no cure. Children who inherit SMA are missing a gene that produces a protein which directs nerves in the spine to give commands to muscles. Lorson's lab focuses on targeting a partially functioning back-up copy of the missing gene, known as SMN-2, into producing the needed protein.

While the results are promising, Lorson notes additional research is needed before synthetic RNA could be used on humans for SMA. Clinical trials for similar synthetic RNAs are currently being performed in other neurodegenerative disease such as Lou Gehrig's or ALS. In SMA, there are clinical trials taking place in many labs across the country that are investigating drug compounds to increase SMN-2 protein production.

"It's been remarkable to watch how quickly SMN-2 knowledge has transformed from basic molecular biology to being modified targets for novel therapeutics," Lorson said. "SMN-2 is like a light that's been dimmed, and we're trying anything to get it brighter. Even turning it up a little bit would help dramatically."


'/>"/>

Contact: Steven Adams
AdamsST@missouri.edu
573-882-8353
University of Missouri-Columbia
Source:Eurekalert

Page: 1

Related medicine news :

1. Researchers search for culprit behind dry eyes, mouths and more
2. MU researchers develop tool that saves time, eliminates mistakes in diabetes care
3. Researchers discover new way to form extracellular vesicles
4. Researchers discover Achilles heel in lethal form of prostate cancer
5. Jackson Laboratory researchers uncover steps in synapse building, pruning
6. UCLA stem cell researchers uncover mechanism that regulates human pluripotent stem cell metabolism
7. Ben-Gurion University of the Negev researchers achieve male fertility breakthrough
8. Canadian researchers find potential new leukemia treatment with old antibiotic drug
9. FDA funds Rochester researchers to give chronic and acute pain clinical trials a makeover
10. Jefferson researchers study outcomes of carotid artery stenting following prior carotid procedure
11. Researchers gain insight into 100-year-old Haber-Bbosch process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2014)... in massive health care spending, a new RAND study ... to incentivize pharmaceutical companies and device makers to develop ... existing medical technologies and their use, a new study ... and medical devices get created in the first place. ... with as little loss of health as possible and ...
(Date:4/22/2014)... Mich. Nearly 7 in 10 Americans support ... new national survey by researchers at the University of ... children under the age of 18 at home, and ... likely than other adults to support universal coverage of ... in the Journal of the American Medical Association ...
(Date:4/22/2014)... This news release is available in German . ... F. Perutz Laboratories of the University of Vienna and the ... Zurich, have now shown how double stranded RNA, such as ... a cell. During the immune response against viral infection, the ... cytoplasm. There it modifies viral RNA to inhibit reproduction of ...
(Date:4/22/2014)... When mothers are exposed to trauma, illness, alcohol or ... molecular trigger in brain cells that can go awry ... and some forms of autism. , Until now, it ... the cells of a developing brain. Past studies have ... alcohol or drug abuse or she experiences some trauma ...
(Date:4/22/2014)... chronic inflammatory disorders of the intestine that result in ... in the U.S., and while there are treatments to ... , Now, Cincinnati Cancer Center and University of Cincinnati ... in her lab have done what is believed to ... important function for the Ron receptor, a cell surface ...
Breaking Medicine News(10 mins):Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3Health News:More than two-thirds of Americans support mandated coverage of birth control in health plans 2Health News:How the body fights against viruses 2Health News:How the body fights against viruses 3Health News:Life stressors trigger neurological disorders, researchers find 2Health News:Two genes linked to inflammatory bowel disease 2
... the only over the counter treatment for chronic and acute wounds. ... contamination of wounds and speeds up the healing process. ... ... development of Wound-Be-Gone, all skin injuries, especially large, chronic wounds, can ...
... WASHINGTON, Nov. 18 Over 2 million low-income Medicare,beneficiaries ... in,January. Changes to the 2009 Medicare Part D plans ... premiums they cannot afford or limit,access to their prescriptions, ... Law Center (NSCLC). Part D open enrollment runs from ...
... But research is preliminary, scientists stress , , TUESDAY, Nov. ... a genetic trait that could provide an early indication ... The research, reported Tuesday at the American Association for ... the preliminary stages. , Still, "the benefit would hopefully ...
... A study appearing in Journal of the American ... their healthcare benefits may affect their ability to access ... delay or avoid seeking care. , In the ... across the United States were surveyed. About one-third of ...
... Resource So Families of ,Bad, Children Can Survive - and ... BEACH, Fla., Nov. 18 The holidays should bring peace, ... the season can foster difficult, even disorderly conduct among troubled ... a family gathering and leave parents asking, "What did I ...
... SEATTLE, Nov. 18 Seattle University ... million Opus Prize to Marguerite "Maggy",Barankitse for her ... of,ethnic strife in Burundi, Africa. Two $100,000 winners ... Community and Center for the,Development of Central America, ...
Cached Medicine News:Health News:A Revolution in Wound Healing, Wound-Be-Gone Now the Only Over the Counter Treatment for Chronic and Acute Wounds 2Health News:A Revolution in Wound Healing, Wound-Be-Gone Now the Only Over the Counter Treatment for Chronic and Acute Wounds 3Health News:2009 Medicare Part D Premiums to Rise Dramatically: Over 2 Million Low Income Beneficiaries At Risk 2Health News:Genetic Trait Could Predict Lung Cancer 2Health News:New Site DrNorm.com Offers Hope and Healing to Parents of 'Difficult' Children During Holiday Season & Beyond 2Health News:New Site DrNorm.com Offers Hope and Healing to Parents of 'Difficult' Children During Holiday Season & Beyond 3Health News:Seattle University in Partnership With the Opus Prize Foundation Award $1 Million Opus Prize 2
(Date:1/15/2014)... 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... offer by its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ... stock of Solta Medical, Inc. (NASDAQ: SLTM ...
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... Texas , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... results for the fourth quarter of 2013 on Monday, February ... for release after the close of trading. ... conference call to discuss the operating highlights and financial results ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
... (NYSE: DHR ) announced today that Henk ... and Amir Aghdaei and Henrik Roos have each been ... In his new role, Henk van Duijnhoven will ... Group and Sybron Dental Specialties.  Danaher,s Dental segment generated ...
... ALISO VIEJO, Calif., April 5, 2011 Avanir Pharmaceuticals, Inc. ... will present an overview of the company at the Future Leaders ... Location: Millennium Broadway Hotel & Conference Center, New York, ... Presentation time: 2:00pm ET A live ...
Cached Medicine Technology:Danaher Announces Executive Appointments 2
Complete Cataract Competence , OPMI VISU 140 is compact, good and economical. It's everything a cataract specialist needs today....
BD Vacutainer® Specialty Tubes - Acid Citrate Dextrose (ACD)...
... BD Vacutainer® SST™ Tubes ... a polymer gel for ... used for serum determinations ... provide an efficient means ...
MONOJECT Red/Yellow Mottled Stopper...
Medicine Products: